BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gisbert JP, Calvet X, O'connor JA, Mégraud F, O'morain CA. The sequential therapy regimen for Helicobacter pylori eradication. Expert Opinion on Pharmacotherapy 2010;11:905-18. [DOI: 10.1517/14656561003657152] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Song ZQ, Liu J, Zhou LY. Hybrid Therapy Regimen for Helicobacter Pylori Eradication. Chin Med J (Engl). 2016;129:992-999. [PMID: 27064046 DOI: 10.4103/0366-6999.179803] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
2 Kadayifci A, Uygun A, Kilciler G, Kantarcioglu M, Kara M, Ozcan A, Emer O. Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection. Helicobacter. 2012;17:121-126. [PMID: 22404442 DOI: 10.1111/j.1523-5378.2011.00924.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
3 Schwarzer A, Urruzuno P, Iwańczak B, Martínez-gómez M, Kalach N, Roma-giannikou E, Liptay S, Bontem P, Buderus S, Wenzl T, Koletzko S. New Effective Treatment Regimen for Children Infected With a Double-resistant Helicobacter pylori Strain. Journal of Pediatric Gastroenterology & Nutrition 2011;52:424-8. [DOI: 10.1097/mpg.0b013e3181fc8c58] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
4 Sánchez-Delgado J, García-Iglesias P, Castro-Fernández M, Bory F, Barenys M, Bujanda L, Lisozain J, Calvo MM, Torra S, Gisbert JP. High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates. Aliment Pharmacol Ther. 2012;36:190-196. [PMID: 22591220 DOI: 10.1111/j.1365-2036.2012.05137.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
5 den Hollander WJ, Kuipers EJ. Current pharmacotherapy options for gastritis. Expert Opin Pharmacother. 2012;13:2625-2636. [PMID: 23167300 DOI: 10.1517/14656566.2012.747510] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
6 Erdur B, Ozturk Y, Gurbuz ED, Yilmaz O. Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance. J Pediatr Gastroenterol Nutr. 2012;55:530-533. [PMID: 22465935 DOI: 10.1097/mpg.0b013e3182575f9c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Yan W, Gu L, Ren W, Ma X, Qin M, Lyu M, Wang S. Recognition of Helicobacter pylori by protein-targeting aptamers. Helicobacter 2019;24:e12577. [PMID: 30950149 DOI: 10.1111/hel.12577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
8 Prieto-Jimenez CA, Cardenas VM, Fischbach LA, Mulla ZD, Rivera JO, Dominguez DC, Graham DY, Ortiz M. Double-blind randomized trial of quadruple sequential Helicobacter pylori eradication therapy in asymptomatic infected children in El Paso, Texas. J Pediatr Gastroenterol Nutr. 2011;52:319-325. [PMID: 21336156 DOI: 10.1097/mpg.0b013e318206870e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
9 Masjedizadeh AR, Hajiani E, Jalal Hashemi S, Alavinejad P, Dalvand H. Sequential Therapy vs Quadruple Therapy for Helicobacter pylori Eradication in South West of Iran. Euroasian J Hepatogastroenterol 2014;4:63-6. [PMID: 29699349 DOI: 10.5005/jp-journals-10018-1103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Lai CH, Rao YK, Fang SH, Sing YT, Tzeng YM. Identification of 3’,4’,5’-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells. Bioorg Med Chem Lett. 2010;20:5462-5465. [PMID: 20705463 DOI: 10.1016/j.bmcl.2010.07.094] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
11 Talebi Bezmin Abadi A. Therapy of Helicobacter pylori: present medley and future prospective. Biomed Res Int. 2014;2014:124607. [PMID: 24800203 DOI: 10.1155/2014/124607] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
12 Basarab GS, Hill P, Eyermann CJ, Gowravaram M, Käck H, Osimoni E. Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: Incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty. Bioorganic & Medicinal Chemistry Letters 2012;22:5600-7. [DOI: 10.1016/j.bmcl.2012.07.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]